Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine
about
sameAs
Understanding engineered nanomaterial skin interactions and the modulatory effects of ultraviolet radiation skin exposureApplication of sub-micrometer vibrations to mitigate bacterial adhesionEfficacy and safety of nanohybrids comprising silver nanoparticles and silicate clay for controlling Salmonella infection.Positive effect of propolis on free radicals in burn wounds.Toxicity of Ag, CuO and ZnO nanoparticles to selected environmentally relevant test organisms and mammalian cells in vitro: a critical review.Propolis Modifies Collagen Types I and III Accumulation in the Matrix of Burnt Tissue.Bee Pollen as a Promising Agent in the Burn Wounds Treatment.In vitro and in vivo evaluation of biologically synthesized silver nanoparticles for topical applications: effect of surface coating and loading into hydrogels.Nanoparticles as multifunctional devices for the topical treatment of cutaneous leishmaniasis.Role of silver nanoparticles (AgNPs) on the cardiovascular system.Capping Agent-Dependent Toxicity and Antimicrobial Activity of Silver Nanoparticles: An In Vitro Study. Concerns about Potential Application in Dental Practice.The potent antimicrobial properties of cell penetrating peptide-conjugated silver nanoparticles with excellent selectivity for gram-positive bacteria over erythrocytes.Size-dependent antibacterial activities of silver nanoparticles against oral anaerobic pathogenic bacteria.Silver Nanoparticles Stabilised by Cationic Gemini Surfactants with Variable Spacer Length.Transdermal uptake and organ distribution of silver from two different wound dressings in rats after a burn trauma.Toward revealing the controversy of bacterial biosynthesis versus bactericidal properties of silver nanoparticles (AgNPs): bacteria and other microorganisms do not per se viably synthesize AgNPs.Antibacterial Activity of Partially Oxidized Ag/Au Nanoparticles against the Oral Pathogen W83
P2860
Q23920953-4E7023FB-9866-4252-B01D-99D07B629C43Q30436824-D4C6563D-2B20-4510-965B-E37463B249ADQ35997969-5251BA2D-537F-4236-B0B7-195EFAACF4CFQ36914134-87049FA1-BECA-447A-A14B-F0B474BD6B68Q36917097-56C5E914-4AD2-4F80-8999-5B10A0A27531Q36921622-A0BE27DA-2370-491A-8096-5EB327310561Q36953074-1361E0EC-FCE3-40BA-8173-65DF1DCBC949Q37610470-574D1C9C-D803-4C40-8FD1-16C343E25BA6Q38195310-C667AEE7-62FC-4662-A447-97C4EE4DC6EDQ38301573-7DAD0FC2-B9AB-44DA-9F17-0DF1450A64D6Q40495119-E27E4D02-3160-463A-8D82-908FD6EDC09AQ45904432-0BAB270D-1D10-4AA9-8266-A6124EDBC1A0Q47252090-A5F42C66-3879-4B55-B397-418A6BC754F6Q47728256-64E542E2-2D29-4570-9564-A06773F62F28Q48595370-DB638112-A5FA-4D84-AC64-801D76B431A9Q51654568-8B2216EC-CA2F-47FB-8178-89CCFD1EC6D9Q59128973-E8B3F76F-6234-4CAE-9A0C-85CFF59DA156
P2860
Nanoscalic silver possesses broad-spectrum antimicrobial activities and exhibits fewer toxicological side effects than silver sulfadiazine
description
im Mai 2012 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в травні 2012
@uk
name
Nanoscalic silver possesses br ...... fects than silver sulfadiazine
@en
Nanoscalic silver possesses br ...... fects than silver sulfadiazine
@nl
type
label
Nanoscalic silver possesses br ...... fects than silver sulfadiazine
@en
Nanoscalic silver possesses br ...... fects than silver sulfadiazine
@nl
prefLabel
Nanoscalic silver possesses br ...... fects than silver sulfadiazine
@en
Nanoscalic silver possesses br ...... fects than silver sulfadiazine
@nl
P2093
P50
P1476
Nanoscalic silver possesses br ...... fects than silver sulfadiazine
@en
P2093
Alexander E Egger
Alexander E. Egger
Beat Mueller
Bernhard K. Keppler
Christian Strupp
Oliver Brandt
P356
10.1016/J.NANO.2011.07.005
P407
P577
2012-05-01T00:00:00Z